INS and pancreatic neuroendocrine tumor: NICTH typically presents with spontaneous hypoglycemia, resembling the hypoglycemia seen in functioning islet-cell tumors, but without elevated insulin levels [6]. However, symptoms related to the tumor mass effect may also precede hypoglycemia onset.